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Male Reproductive Toxicology: Comparison
of the Human to Animal Models
by Peter K. Working*
The human male is ofrelatively lowfertility and thus may be at greaterriskfrom reproductive toxicants
than are males ofthe common laboratory animal model species. Lack of knowledge ofthe physiological
differences that contribute to interspecies variation between man and animals can prevent the effective
application of animal data to the assessment of human reproductive risk. Evaluation of spermatogenesis
from testicular histology, while uncommon, can provide valuable information about human reproductive
risk. The measurement of sperm count or concentration has long been the most feasible approach for
human semen evaluation, but may be an insensitive indicator of reproductive function because of high
sample-to-sample variability. Interspecies extrapolation factors can be calculated by comparing the re-
duction in sperm count in humans and test species after exposure to drugs or chemicals. These factors
can provide a realistic assessment ofrelative risk, provided that the sperm are counted at the appropriate
time after exposure. However, the degree to which extrapolation factors derived for one agent, and only
from sperm counts, can be generalized is not known. Monitoring of sperm motility and morphology
parameters is also a common means of evaluating human semen quality, but these techniques are also
hampered by the relatively high interindividual and intersample variability. Computer-assisted and mor-
phometric approaches showpromise ofdecreasingthe subjective nature oftheseevaluationsandincreasing
their value in risk assessment procedures. Improvements in predicting human reproductive risk can be
expected tc. come from increased knowledge about reproductive mechanisms in man and animals, together
with the utilization of objective measures of cellular indicators of male reproductive function.
Introduction
The human male is ofrelatively low fertility as com-
pared to most animal species. An estimated 15 to 20%
of all American couples are infertile (1), less than one-
third of all conceptions result in a live birth (2), and
some20to30%ofalldevelopmentaldefectshavegenetic
origins (3). Although between 10 and 20 chemicals or
drugs have been directly demonstrated to adversely
affect human male reproduction (1), the majority of our
information concerning reproductive toxicants has been
collected using animal models. Thus, the scientific pro-
cess for the evaluation ofhuman reproductive risk from
drugs and chemicals includes extrapolation from data
obtained using these models. Yet, interspecies differ-
ences may prevent the effective application of infor-
mation gained from the study of animal species to the
assessmentofhumanrisk, andthelackofunderstanding
of the factors contributing to differences in response
among species will inevitably weaken the conclusions
drawn from such studies. Thisreport compares and con-
trasts several indices of reproductive efficiency in ani-
mals and man. The discussion is not intended to be a
comprehensive review of interspecies extrapolation or
ofthe characteristics ofanimalmodels. For more details
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in these important areas, the reader is directed to sev-
eral excellent reviews on both subjects (4-13).
Nature of Interspecies Variability
Interspecies variation in response to toxic chemicals
can arise from differences in many parameters. Data
gathered from humans may differ from data from test
species for procedural reasons, including variations or
inconsistencies in statistical treatment of the data, in
the design of the animal study (including dosing con-
centration and route of administration ofthe test com-
pound), or in the epidemiological evaluation procedures
in the human study (9). Major variability in response
occurs because ofgenetic and physiological differences
between animals and man (Table 1). Several recent vol-
umes (4-6) have catalogued the physiological and toxi-
cological basis for the expression of interspecies vari-
Table 1. Possible physiological differences among species.
Genetic variability
Metabolism
Enzyme types and specificities
Kinetics
Intracellular pathways oftoxicity
Membrane biochemistry and receptors
Absorption, distribution, storage, and excretion
Specific organ functionP. K. WORKING
ation, and recent reviews have dealt with more specific
issues, including comparative drugmetabolism (10), the
use of scaling factors for relating species body size to
various physiological and pharmacokinetic characteris-
tics (8), and the efficacy ofusing animal models to pre-
dict the potential chronic effects oftoxic xenobiotics (9).
Geneticdifferences accountformanyofthe variations
thatoccurbetweenanimals andman; physiologicalfunc-
tions oftenvary not only amongspecies but even among
strains of the same species (9). The variations may be
expressed as both quantitative and qualitative differ-
ences in the metabolism of drugs and chemicals, for
example. DBA/2J mice are resistant to aryl hydrocar-
bon hydroxylase induction by 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD), as compared to C3H or C57BL/
6J strains, at least in part because of a lower concen-
tration ofTCDD-specific cellularreceptors (14,15). Sim-
ilarly, the differential toxicity ofmethyl chloride in rats
and mice is thought to be related to species-specific
variations in glutathione conjugation of the chemical
(16). Some interspecies differences may be minimal, as
in the case of oral and pulmonary absorption or pul-
monary and renal excretion (which are generally com-
parable among vertebrate species), but others are pro-
nounced, as in the case of dermal absorption (which
varies because ofmorphological differences among spe-
cies) (8). Similarly, storage and distribution of com-
pounds tends to differ little among vertebrate species,
but more significant variations may occur in target or-
gan sensitivity, membrane receptors, and enzyme ki-
netics (7).
Differences in specific organ function may play a par-
ticularly large role in the etiology ofanimal/human var-
iation in reproductive risk. In general, the human male
is likely at relatively greater risk from toxic agents
because ofdifferences in gonadal function. The number
of sperm per human ejaculate is typically only two- to
fourfold higher than the number at which fertility is
significantly reduced (17), whereas thenumberofsperm
in a rat, rabbit, or bull ejaculate is many times (up to
1400-fold) the numberwhich willproduce maximum fer-
tility (11). Toillustrate, inexperiments whereratswere
surgically or chemically rendered oligospermic, Aafjes
and co-workers (18) reported that epididymal sperm
counts could be reduced as much as 90% without sig-
nificantly affecting fertility. Other species differences
in reproductive parameters are summarized in Table 2,
which has been compiled from the literature. Although
somespermatogenesis parameters aresimilar, notethat
human males have markedly smaller relative testis size
and the lowest rate ofdaily sperm production per gram
testis by a factor of more than three. Moreover, the
percentages of progressively motile sperm and mor-
phologically normal sperm in human semen are lower
in man than in any of the animal models studied (13).
The relative fertility ofhumans and ofanimal models
is portrayed in Figure 1. Assuming a relationship be-
tween some theoretical reproductive parameter "X"
(e.g., sperm number, motility, production rate, etc.)
Table 2. Species differences in reproductive parameters.a
Parameter Mouse Rat Monkey Human
Duration of cycle of 8.6 12.9 9.5 16.0
seminiferous epithelium,
days
Duration of 35 52 38 74
spermatogenesis, days
Testes weight, g 0.2 2.6 49 34
Daily sperm production
Per gram testis, 106/g 28 18 23 4.4
Per male, 106 5 48 1100 125
Sperm reserves in 49 440 5700 420
cauda, 106
Epididymal transit time, 5.0 7.2 10.5 5.5
days
aData compiled from the literature (13,41,43).
and fertility, animal models are far to the right on the
plateau of maximum fertility. Human males, on the
other hand, are much nearer the minimum X required
(Fig. 1A). Given a 60 to 80% decrease in parameter X,
males oftheusualtest speciesremainmaximallyfertile,
but fertility in the human male begins to be compro-
mised (Fig. 1B). It is also clear from this diagram that
the fertility of animal models may be an insensitive in-
dicator of human reproductive risk.
Usingspecialized laboratoryprocedures, itispossible
tobringthefertilityofanimaltestspeciesintotherange
ofhuman fertility (i.e., to move them to the left on the
fertility curve in Figure 1, in the region indicated by
the arrow). For example, artificial insemination pro-
cedures can decrease the efficiency ofthe reproductive
process in animals by decreasing the number of sperm
inseminated (13) and thus increase the sensitivity ofthe
fertility test. Alternatively, the sensitivity of natural
breedingstudies canbeimprovedbydecreasingthe size
ofthe large sperm reserves in rats by using a protocol
ofcontinuous breedingpriortotesting(19). Byreducing
epididymal sperm reserves, this technique produces a
rat which, in terms of its reproductive efficiency, is
apparently much more like a human. These and other
procedures that take into account the physiological dif-
ferences between model species and humans should re-
sult in more sensitive testing procedures to detect fer-
tility changes in humans.
If animal fertility is not a reliable measure ofrepro-
ductive risk to humans, what sort of end points might
be useful? Common laboratory animal tests are listed
in Table 3, along with a summary of their practicality
in rats, rabbits, and humans. These two test species
were selected for emphasis, since rats are commonly
usedintoxicologicalstudiesandhavewell-characterized
reproductive processes and because rabbits are the
smallest species from which ejaculates can be conve-
niently obtained. Rabbits are normally the only species
used in longitudinal studies, in which fertility changes
and seminal parameters are evaluated in the same an-
imal over time. Longitudinal studies can also be per-
formed with rats by recovery of uterine sperm after
matingwithoverectomized, hormonallyprimed females
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Table 3. Reproductive end points.a
End point Rat Rabbit Human
Body weight Yes Yes Yes
Testis
Size in situ Yes Yes Yes
Weight Yes Yes Npb
Spermatid reserves Yes Yes NP
Histology
Tubules with lumen Yes Yes NP
sperm, %
Tubule diameter Yes Yes NP
Epididymis
Weight Yes Yes NP
Sperm number Yes Yes NP
Sperm motility, % Yes Yes NP
Sperm morphology, % Yes Yes NP
Histology Yes Yes NP
Semen
Volume NP Yes Yes
Sperm concentration NP Yes Yes
Total sperm/ejaculate NP Yes Yes
Sperm motility, % NP Yes Yes
Sperm morphology, % NP Yes Yes
Fertility
No. pregnant females Yes Yes NP
No. embryo per female Yes Yes NP
No. unfertilized eggs Yes Yes NP
In vitro
Fertilization Yes Yes NP
Hamster egg penetration NAC NA Yes
aAdapted from Bedford (11).
bNP, not practical.
cNA, not necessary.
and animal spermatogenesis and testicular histology
should be emphasized.
Reproductive Parameter 'X'
FIGURE 1. Idealized fertility curve, illustrating relative fertility of
man (H) and common laboratory animalmodels (M), plotted versus
some theoretical reproductive parameter, "X." (A)The position of
normal model species and humans reflects the greater reproduc-
tive competence ofthe test species. The arrowindicates theregion
to which fertility should be reduced to increase the sensitivity of
animal models. (B)After a 60% reduction in parameter X, the
model species is stillfullyfertile, buthumanfertility has decreased
from maximum.
(20). The sperm recovered are not directly comparable
to ejaculated human sperm, as the ejaculate has been
diluted by vaginal and uterine fluids and the cells have
passed through the cervix, which may act as a barrier
to abnormally shaped or functioning sperm. Thus, pa-
rameters measured in this population may not be rep-
resentative of the ejaculate as a whole, and therefore
not directly comparable to human ejaculated sperm.
Studies ofcomparative testicular histology in humans
and animal models can provide valuable information
about the effect of drugs and chemicals on sperm pro-
duction rates and spermatogonial survival. Although
similar in many respects, certain differences in human
Comparative Testicular Histology
Spermatogenesis is the process by which spermato-
gonial stem cells divide and differentiate to spermato-
zoa, and methods for its critical evaluation have been
thoroughly reviewed (21). The spermatogenic cycles of
man and animals have many similarities: each step of
the process is precisely timed and complex associations
of cells mature in synchrony (22). In any given area of
the seminiferous epithelium, there are five or six gen-
erations ofgerm cells that appeartogether, formingcell
associations of definite and fixed composition (23). Spe-
cifically, one or two generations of spermatids are al-
ways associated with one or two generations of sper-
matocytes and with spermatogonia at given stages of
their development. Each cell association, which can be
classified by cytological or histological criteria, forms a
stage ofspermatogenesis, andfrom6 (human) to 14(rat)
stages have been described (23,24). The cycle of the
seminiferous epithelium consists ofthe complete series
of spermatogenic stages as they appear sequentially
over time in the same area of the seminiferous epithe-
lium. The length of the cycle corresponds to the time
from the disappearance of one particular stage to its
A
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reappearance in the same area ofthe seminiferous tub-
ule, and ranges from 8.6 days in the mouse to 16 days
in humans (Table 2). The duration of spermatogenesis,
i.e., the length oftime it takes for a given stem cell to
produce mature spermatozoa, corresponds tothe length
of approximately 4 to 4.5 cycles in laboratory animals
and humans (ranging from 35 days in the mouse to 74
days in humans).
A cross-section of a mammalian testes displays nu-
merous cross-sections ofthe seminiferous tubules (Fig.
2). In most mammals, the stages of spermatogenesis
appear not only sequentially in time, but also sequen-
tially in space (alongthe length ofthe seminiferous tub-
ule). This so-called wave ofthe seminiferous epithelium
(Fig. 3) has been described for numerous model species
(25) and results from the synchronous differentiation of
the cellular associations. The serendipitous result ofthe
wave is that each seminiferous tubule will be of only
one spermatogenic stage when viewed in cross-section
(Fig. 3). This considerably eases the job of the pathol-
ogist who wishes to quantify the toxic effects of drugs
and chemicals in the animal testis.
In contrast, the arrangement of germ cells in the
human seminiferous epithelium appears relatively cha-
otic when the tubule is viewed in whole mount. Specific
cellular associations (ofwhich there are six) are seen to
appear in irregular zones throughout the seminiferous
epithelium (Fig. 4), and there are frequent heteroge-
neous stages, characterized by the inappropriate pres-
ence or absence ofgerm cells in typical cell associations
(24). Thus, a cross-section through a tubule will reveal
a mixture of cells of different stages (Fig. 4). More
recently, Schulze and Rehder (26) utilized morpholog-
ical and morphometric procedures to studyhuman sper-
matogenesis. They report that, rather than being hap-
hazardly arranged, increasingly mature spermatocyte
populations are arranged on helices that are contracted
conically toward the lumen ofthe seminiferous tubule.
These authors note that this arrangement may be a
natural outcome of the markedly lower rate of sper-
matogonial division in humans as compared to other
mammals. Nonetheless, a typical cross-section oftestis
willpresent anappearance similartothatseeninFigure
4. As a result, quantitation of toxic effects on sperma-
togenesis is a much more difficult task in humans, and
direct comparison to animal models may not always be
possible or warranted. Other, more quantitative, meth-
ods have been described for determination of sperm
production rates from testicular histology in humans,
including enumeration of spermatocytes and/or deter-
FIGURE 2. Cross-section of rat testis. Periodic acid-Schiff and hematoxylin, x 750.
40HUMAN MALE REPRODUCTIVE TOXICOLOGY
VI
b. L
V IV~~~~~~~~~~~~~~L
FIGURE 3. Wave of spermatogenesis in the rat, typical of most model species. Seminiferous tubule showing sequential appearance of sper-
matogenic stages (as defined by Leblond and Clermont) along the length of the tubule. Cross-sections of the testis, cut at (a) or (b), will
exhibit individual tubules as diagrammed. Each tubule contains only one stage of spermatogenesis.
FIGURE 4. Pattern of spermatogenesis in the human seminiferous
tubule. Viewed longitudinally, the seminiferous tubule exhibits an
apparently random distribution of spermatogenic stages because
of the helical arrangement of sequentially more mature sperma-
togenic stages. Cross-sections cut at (a) or (b) will exhibit several
stages of spermatogenesis in the same section.
mination of spermatid number (21,27) and can also be
applied to assess reproductive toxicityiftesticular sam-
ples can be obtained.
Because of difficulties in obtaining human testicular
biopsies, assessments of reproductive toxicity in hu-
mans are commonly restricted to the analysis ofsemen
or sperm quality, including sperm concentration and
count, the percentage of motile sperm, and the per-
centage of sperm with abnormal morphology. Ejacu-
lates cannot effectively be obtained from the rat, and
epididymal sperm samples cannotroutinely be obtained
from humans, so comparative studies ofrat and human
sperm quality must perforce compare epididymal rat
sperm to ejaculated human sperm. How do these end
points compare in humans and animal models?
Comparison of Sperm Counts
Humans have markedly lower rates of sperm pro-
duction and overall sperm counts than do the usual an-
imal models (Table 3). Measurement ofsperm numbers
has long been the most feasible and, thus, the most
common method for the evaluation of human semen
quality. However, although 20 million sperm per mil-
liliteriswidelyregarded asthelowerlimitofthenormal
sperm count (12), over 80% of infertile males are re-
ported tohave higher counts (28), suggestingthat some
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otherreproductive parameteris also contributing tothe
infertility. Thus, sperm counts, though easy to obtain,
may not be the most sensitive of indices for infertility
or even testicular toxicity. Indeed, coefficients of var-
iation (CV) ofover0.50 have beenreported forrepeated
sperm counts from fertile donors over aperiod of1 year
(12), and we have measured CVs as high as 0.89 in
counts from over 500 semen samples from 159 men
(Working and Levine, unpublished). Variance in sperm
counts andconcentrations in semen orepididymal sperm
from test species is markedly lower (around 0.25-0.35),
but still high enough to hinder the ready detection of
reproductive effects.
Comparisons of the reduction in sperm count in hu-
mans and animal models after exposure to drugs or
chemicals can be useful, provided that appropriate time
points for the sperm count are selected. Interspecies
extrapolation factors (IEF), which are ratios ofthe dose
of a drug or chemical needed to produce a given reduc-
tion in sperm count in a model species to that required
in humans, have been calculated for several chemo-
therapeutic drugs and ionizing radiation (30,31). When
the IEF is low, there is low relative risk to humans
(i.e., a much larger dose is required in humans than in
animals to cause equivalent reductions in sperm count).
Conversely, when the IEF is high, the human repro-
ductive risk is high.
Meistrich and co-workers note that the time at which
sperm counts are determined will varywiththe celltype
affected by treatment and with the kinetics of sper-
matogenesis. Thus, selection of the proper time point
for quantitation of sperm number is essential. For ex-
ample, the IEF determined after exposure to ionizing
radiation (31) is approximately three (meaningthat man
is three times more sensitive than mouse) when sperm
counts are made at the point when they reach a mini-
mum (only 4 days in mouse, over 150 days in man).
These data suggest that the survival of different cell
stages is being measured in mouse and man, so IEFs
based on the time of minimum counts are likely to be
misleading. Alternative methods for calculating IEFs
use sperm counts obtained at the minimum time when
stem cells could have matured to sperm, which yields
an IEF of 11 to 21 (31). However, this method may
overestimate the relative human risk because ofknown
species differences in the repopulation kinetics of stem
cells. In animals, stem cell regeneration and seminif-
erous epithelium repopulation (with concomitant sperm
production) typically begin simultaneously (32). In con-
trast, current evidence suggests that epithelial repop-
ulation in humans does not begin until the entire stem
cell population has been replenished (33). Sperm count
recovery in human males has been reported to take as
long as 3 to 4 years after exposure (34). A final method
for obtaining an IEF is to perform sperm counts at the
time when recovering counts have reached amaximum,
yielding, for animals and humans exposed to ionizing
radiation, an IEF ofabout one (31). This last value will
not be influenced by variations in spermatogenic kinet-
ics among species, or by the particular cell stage dam-
aged, and may be the most accurate means ofderiving
IEF values.
The degree to which IEFs obtained from acute ex-
posures to chemotherapeutic agents or ionizing radia-
tion and derived only from sperm counts can be gen-
eralized is not known (35). In theory, however, IEFs
once derived can be applied to data from animal studies
to predict human risk in the absence of human data.
Comparison of Sperm Motility
Quantitation of sperm motility is a common means for
assessing the quality of semen samples collected during
routine clinical studies. Therelationshipbetween sperm
motilityandfertilityinhumanshaslongbeenrecognized
(36), andthedetermination ofspermmotion parameters
has proven to be a valuable diagnostic tool in assessing
the quality ofhuman semen (37-39). Toxicological stud-
ies of the reproductive effects of chemical exposure in
animals also often assess the quality of epididymal
sperm or spermin semen as anindicatorofreproductive
function, usually by subjective visual assessments of
sperm movement (11,40).
Although subjective measures of sperm motility may
not be useful for accurately assessing relative animal
and human reproductive risk, numerous methods for
the objective determination ofhuman and animal sperm
motility and velocity have been developed in recent
years. The most convenient and practical of these are
videomicrographic methods, which are often computer-
assisted (29,38,41-43). Using standard videomicro-
graphic techniques, Blazak et al. (41) reported a CV of
0.16 for the percentage of motile sperm determined in
single samples from 15 adult Fischer 344 rats, and we
measured a CV of 0.15 for the percentage of motile
sperm in samples from 50 adult rats using a computer-
assisted motility analyzer (43) (Table 4). Slightly more
biological variation is seen in human samples. Katz et
al. (29) calculated an overall CV of 0.27 for percent
motility in repeated semen samples from fertile donors
over 1 year, with per man CVrangingfrom0.12 to 0.49.
In more recent work (Working and Levine, unpub-
lished), using a computer-assisted videomicrographic
system, we determined aCV of0.35forpercentmotility
in over 500 semen samples from 159 men ofunspecified
fertility, and CVs ranging from 0.06 to 0.48 per man for
four repeated samples from the same donors over a 6-
month period (Table 4).
Table 4. Videomicrographic assessment of percentage
motile sperm.
Species n Range, % Mean, % CV
Rata 10 38-62 50 0.16
Ratb 50 39-82 61 0.15
Humanc NGd NG 68 0.27
Humane 538 17-98 62 0.36
aBlazak et al. (41).
bWorking and Hurtt (43).
cKatz et al. (29).
d NG, not given.
eWorking and Levine, unpublished.
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Sperm swimming speed can also be measured using
videomicrographic procedures, and this parameter ex-
hibits somewhat less variability (Table 5). The CV for
mean swimming speed in sperm from 10 rats was 0.07
(41) andinsperm from50ratswas0.09 (43). Onceagain,
human samples had similar, but somewhat higher, var-
iance. Repeated samples from fertile donors yielded an
overall CV of0.19, with a per man range of0.06 to 0.31
(29). In our study, the CV for mean swimming speed
for sperm from 538 semen samples was 0.20, with per
man values (from four samples over a 6-month period)
ranging from 0.02 to 0.49 (Working and Levine, un-
published).
Clearly, the percentage of motile sperm and mean
swimming speed parameters are more invariant than
sperm count, which had CVs ranging from 0.24 in the
rat (41) to over 0.80 in the human (29). These more
stable values may provide a better indicator of toxic
effect and may be of more value in discriminating be-
tween fertile and nonfertile human samples than simple
sperm counts or concentrations.
Comparison of Sperm Morphology
Sperm morphology can be assessed both subjectively
and objectively, and by either method it is clear that
human semen typically contains a high percentage of
abnormally shaped sperm (44); indeed, men are not con-
sidered to have a fertility problem until the frequency
of abnormal cells exceeds 50% (12). Most test species
have much lower proportions of abnormal cells, gen-
erally less than 5%, and the wide variety ofsperm head
shapes in test species often precludes the direct com-
parison of alterations in sperm head shape in animals
and man.
Subjective measures ofhuman spermmorphology are
complicated by interlaboratory and interscorer varia-
bility in the assignment ofsperm shapes to user-deter-
Table 5. Videomicrographic assessment of sperm velocity.
Range, Mean,
Species n pum/sec Rm/sec CV
Rata 10 40-76 69 0.07
Ratb 50 42-94 69 0.15
Humane NGd NG 48 0.27
Humane 538 23-64 44 0.20
aBlazak et al. (41).
bWorking and Hurtt (43).
'Katz et al. (29).
dNG, not given.
eWorking and Levine, unpublished.
Table 6. Comparison of morphometric parameters.a
Fertility Length, Width, Length/ Length x
status pum pum width width, pmm2
Fertile 4.37 ± 0.58 2.83 ± 0.32 1.56 ± 0.28 12.37 ± 2.19
Infertile 4.41 ± 0.66 2.68 ± 0.36b 1.68 ± 0.36b 11.76 ± 2.26
aKatz et al. (46). "Significantly different from control (p : 0.05).
mined morphological categories, but the development
of standard classification schemes has partially solved
this problem (44,45). Also promising are videomicro-
graphic-based methods for the morphometric analysis
ofspermmorphology(46,47), inwhichspermheadshape
and size characteristics are measured using image
analysis techniques. Using such an approach, Katz and
co-workers (46) measured the maximum width and
length and the circumference ofthe human sperm head
in single specimens from fertile and infertile men (Table
6). There was greater variability per ejaculate in infer-
tile men, and the length/width ratio effectively distin-
guished the fertile and infertile groups, suggestingthat
this method may have some utility as an indicator of
reproductive changes. Methods for the objective mea-
surement ofanimal sperm morphology that use similar
morphometric techniques (48) or flow cytometry (49)
have also been developed and may permit more direct
comparison ofexposure-related changes in sperm head
morphology in test species and the human male.
Clearly, no single reproductive end point in any lab-
oratory animal model can serve as an accurate indicator
of reproductive risk in the human male. Current pro-
cedures that use laboratory models are often inade-
quate, usually becausethey aretoo subjective andfairly
insensitive. Many approaches pay little attention to the
physiological differences between man and the common
testspecies, and thus fall shortintheirabilitytopredict
human reproductive hazard. Future improvements can
be expected to come from increased knowledge about
reproductive mechanisms in man and animals, together
with the utilization of objective measures of cellular
indicators (e.g., spermmotilityandmorphology) ofmale
reproductive function and of test procedures that in-
crease the sensitivity ofthe animal modelsystems (e.g.,
artificial insemination).
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